Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
European Neurology
|
January 11, 2007
Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement
Pierre Mégevand, Carlo Chizzolini, Michel Chofflon, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
|
July 20, 2002
Isolated unilateral adduction deficit and ptosis as the presenting features of chronic inflammatory demyelinating polyradiculoneuropathy
Christina Pieh, Beatrice Rossillion, Anne C Heritier-Barras, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society
|
September 16, 2009
Increasing the diagnostic value of evoked potentials in multiple sclerosis by quantitative topographic analysis of multichannel recordings
Agustina M Lascano, Verena Brodbeck, Patrice H Lalive, et al.
Topics in Magnetic Resonance Imaging : TMRI
|
December 29, 2010
Magnetic resonance imaging in multiple sclerosis
Sven Haller, Vitor Mendes Pereira, Patrice H Lalive, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 25, 2010
Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells
Mahdia Benkhoucha, Marie-Laure Santiago-Raber, Gregory Schneiter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2009
Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis
Danielle Burger, Nicolas Molnarfi, Martin S Weber, et al.
Plos One
|
January 7, 2011
Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease
Martin S Weber, Mahdia Benkhoucha, Klaus Lehmann-Horn, et al.
Current Medical Research and Opinion
|
October 3, 2007
Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis
Douglas S Goodin, Louis D Biermann, Saeed Bohlega, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 30, 2012
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease
Hervé Perron, Raphaëlle Germi, Corinne Bernard, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 10, 2013
Re: Errors in the editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 1670-1672]
Hervé Perron, Raphaëlle Germi, Corinne Bernard, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
European Neurology
|
January 11, 2007
Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement
Pierre Mégevand, Carlo Chizzolini, Michel Chofflon, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
|
July 20, 2002
Isolated unilateral adduction deficit and ptosis as the presenting features of chronic inflammatory demyelinating polyradiculoneuropathy
Christina Pieh, Beatrice Rossillion, Anne C Heritier-Barras, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society
|
September 16, 2009
Increasing the diagnostic value of evoked potentials in multiple sclerosis by quantitative topographic analysis of multichannel recordings
Agustina M Lascano, Verena Brodbeck, Patrice H Lalive, et al.
Topics in Magnetic Resonance Imaging : TMRI
|
December 29, 2010
Magnetic resonance imaging in multiple sclerosis
Sven Haller, Vitor Mendes Pereira, Patrice H Lalive, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 25, 2010
Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells
Mahdia Benkhoucha, Marie-Laure Santiago-Raber, Gregory Schneiter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2009
Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis
Danielle Burger, Nicolas Molnarfi, Martin S Weber, et al.
Plos One
|
January 7, 2011
Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease
Martin S Weber, Mahdia Benkhoucha, Klaus Lehmann-Horn, et al.
Current Medical Research and Opinion
|
October 3, 2007
Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis
Douglas S Goodin, Louis D Biermann, Saeed Bohlega, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 30, 2012
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease
Hervé Perron, Raphaëlle Germi, Corinne Bernard, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 10, 2013
Re: Errors in the editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 1670-1672]
Hervé Perron, Raphaëlle Germi, Corinne Bernard, et al.
Page
of 2